Representation of the Body for Patients With Cancer

Peritoneal Carcinomatosis Clinical Trial

— CORCAN  

Official title:

Representation of the Body and Treatment of Peritoneal Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - A Collaborative Approach Between Professionals of Health / Patients / Researchers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01560533
• Other study ID #: 2010.640
• Status: Completed
• Phase: N/A
• Start date: November 2011
• Est. completion date: January 2013

Study information

• Verified date: January 2014
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The project aims to understand better how patients live the event of cancer and live its consequences on their bodily representations. In the study, the dynamic of the body image is not restricted to appearance but include sensations and visions of the inner body, what explains the choice of peritoneal cancer, and the treatment by cytoreductive surgery and HIPEC.

The three objectives of the study are:

• identifying the impact of the representations of the treated body on the psychological strategies to cope with the disease, the bodily changes and the prospects of life;

• making explicit the positive or negative impacts of these representations on the relationship between patients and health professionals (easing factors, misunderstandings, negotiations, etc.);

• associating the health professionals with the study in its course and evaluation in order to elaborate a methodological collaborative approach between patients, health professionals and researchers in social sciences.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients eligible to treatment of cancer by cytoreductive surgery and HIPEC

• Primary (pseudomyxoma, mesothelioma) and secondary (colorectal, gastric, ovarian) peritoneal cancer

• Free consent

• Male or Female

• Age > 18 years

• Affiliate to social security

Exclusion Criteria:

• Age < 18 years, no french speaking

• Cerebrals metastasis

• Psychiatrics diseases

Related Conditions & MeSH terms

• Carcinoma
• Peritoneal Carcinomatosis
• Peritoneal Neoplasms

Intervention

Behavioral:
• Interviews
Interviews will be done with patients

Locations

Country	Name	City	State
France	Centre Hospitalier Lyon Sud	Pierre Bénite

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

References & Publications (1)

Durif-Bruckert C, Guilloux R, Guïoux A, Lasserre E, Goffette J, Régnier V. [Qualitative and collaborative research with cancer patients. Experience narratives of treatments for peritoneal carcinomatosis]. Bull Cancer. 2016 Feb;103(2):148-53. doi: 10.1016/ — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Body representations	Comprehensive knowledge concerning the way the patients are living cancer event, treatment, changes in their body representations and conceptions of their lives.; This qualitative study do not include outcome measures. Its purpose is restricted to the meanings	3 months